No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2664 |
4. Check minimum number of eventsNone |
2664 |
5. Include endpointsNone |
2664 |
6. Filter based on genotype QC (FinnGen only) |
2664 |
Control definitions (FinnGen only)
- Control exclude
- D3_COAGDEF_PURPUR_HAEMORRHAGIC
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D69
- Name in latin
- Thrombocytopenia NAS
Similar endpoints
↥List of similar endpoints to
Thrombocytopenia, unspecified
based on the number of shared cases.
Similar with more cases:
- Purpura and other haemorrhagic conditions
- Coagulation defects, purpura and other haemorrhagic conditions
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 20979 | 9790 | 11000 |
| Only index persons | 17647 | 8393 | 9254 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.29 | 0.28 | 0.31 |
| Only index persons | 0.33 | 0.31 | 0.35 |
| Median age at first event (years) | |||
| Whole population | 60.24 | 59.26 | 61.06 |
| Only index persons | 59.45 | 57.70 | 61.04 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2664 | 1256 | 1408 |
| Unadjusted period prevalence (%) | 0.53 | 0.43 | 0.62 |
| Median age at first event (years) | 60.84 | 55.70 | 65.43 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2400
- Matched controls
- 23998
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
16384.0
323.0
2253
14
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
+∞
323.0
509
*
XW000
NOMESCO Finland
Bone marrow biopsy
28.5
323.0
743
372
WW500
NOMESCO Finland
Blood transfusion
17.0
301.0
501
367
D64.9
ICD-10 Finland
Anaemia, unspecified
6.5
219.0
651
1304
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.6
204.7
423
474
D70.82
ICD-10 Finland
Drug-induced neutropenia
19.8
152.0
235
131
D70.89
ICD-10 Finland
Neutropenic splenomegaly
27.2
141.8
198
79
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.6
130.1
300
393
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
126.4
588
1788
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
629.0
122.4
120
*
28719
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia NUD
+∞
121.9
116
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
13.6
119.7
214
171
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
115.3
508
1457
L03AA02
ATC
filgrastim; parenteral
10.3
104.3
214
226
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
103.5
1285
7441
R50.9
ICD-10 Finland
Fever, unspecified
3.4
94.8
541
1894
H02AB06
ATC
prednisolone; systemic
2.4
93.4
1309
7916
D69.5
ICD-10 Finland
Secondary thrombocytopenia
+∞
93.3
89
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.9
91.3
241
381
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
15.1
86.6
147
103
JN4BD
NOMESCO Finland
Extensive body CT
3.5
84.3
446
1459
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
101.4
80.5
88
9
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.9
78.7
362
1050
M04AA01
ATC
allopurinol; systemic
3.1
78.4
508
1919
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
16.7
78.0
127
80
ZX120
NOMESCO Finland
Intravenous
3.6
75.5
382
1198
L03AA14
ATC
lipegfilgrastim; parenteral
11.3
73.3
142
133
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
12.9
72.7
132
108
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
14.7
71.3
122
87
D69.4
ICD-10 Finland
Other primary thrombocytopenia
+∞
70.1
67
*
JN4AD
NOMESCO Finland
Body CT examination
3.8
69.7
321
927
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
62.5
848
4746
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
62.4
513
2219
H02AB02
ATC
dexamethasone; systemic
3.2
61.0
356
1232
A04AA02
ATC
granisetron; systemic, transdermal
4.1
60.3
251
658
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
16.4
60.1
98
62
B02BX05
ATC
eltrombopag; oral
+∞
58.6
56
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
58.3
584
2805
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.5
57.6
157
257
L03AA13
ATC
pegfilgrastim; parenteral
5.7
57.2
173
323
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
55.5
221
555
J01MA12
ATC
levofloxacin; systemic
2.4
55.4
566
2735
A02BC02
ATC
pantoprazole; systemic
2.0
55.2
1579
11767
C03CA01
ATC
furosemide; systemic
2.1
53.1
820
4777
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
53.1
235
649
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
52.8
790
4539
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
51.6
600
3074
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
50.4
860
5192
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
21.2
49.8
74
36
JN6AD
NOMESCO Finland
CT of torso and neck
10.4
49.4
99
99
YNB10
NOMESCO Finland
Collection of stem cells for transplant
71.5
49.2
56
8
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
9.4
49.2
104
115
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.6
47.1
232
700
2875A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia, unspecified
+∞
47.0
45
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.7
46.9
140
257
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
30.3
46.3
62
21
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
46.0
680
3841
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.4
45.4
83
69
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
40.9
44.8
56
14
C83.1
ICD-10 Finland
Mantle cell lymphoma
25.4
44.2
62
25
Z51.5
ICD-10 Finland
Palliative care
3.5
44.1
224
691
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
12.5
44.0
80
66
N02AA05
ATC
oxycodone; systemic
2.3
42.1
430
2045
B01AB10
ATC
tinzaparin; parenteral
3.2
41.6
235
784
WW300
NOMESCO Finland
Transfer of autologic stem cells
22.7
41.5
60
27
A04AA01
ATC
ondansetron; systemic, rectal
3.3
41.4
226
736
D69.1
ICD-10 Finland
Qualitative platelet defects
+∞
40.7
39
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
109.4
39.8
43
*
3039
Kela drug reimbursment
NA
+∞
38.6
37
*
1517
Kela drug reimbursment
NA
+∞
38.6
37
*
D68.8
ICD-10 Finland
Other specified coagulation defects
46.8
37.9
46
10
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
7.7
37.1
88
118
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
34.7
263
1057
TGC00
NOMESCO Finland
Bronchial lavation
4.9
34.6
117
248
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
34.5
561
3232
1XC02
NOMESCO Finland
NA
13.8
33.6
58
43
B03XA02
ATC
darbepoetin alfa; parenteral
6.0
33.1
93
159
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
10.9
32.7
63
59
D69.0
ICD-10 Finland
Allergic purpura
73.2
31.9
36
5
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.3
31.6
167
530
WZC30
NOMESCO Finland
Teaching
2.2
31.5
354
1741
6BA02
NOMESCO Finland
NA
24.9
31.4
44
18
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.2
31.1
53
38
AA1AD
NOMESCO Finland
CT of head and brain
1.9
31.0
587
3555
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
31.0
139
387
XX3DW
NOMESCO Finland
Time consuming IT work
2.4
30.6
289
1306
H02AB07
ATC
prednisone; oral
2.1
30.1
370
1893
R18
ICD-10 Finland
Ascites
6.0
29.5
83
142
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
12.6
29.5
53
43
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
29.3
213
834
2873A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]
+∞
29.2
28
*
R04.0
ICD-10 Finland
Epistaxis
2.6
29.2
221
885
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
28.9
286
1323
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
28.7
141
423
L01CB01
ATC
etoposide; systemic
17.0
28.4
45
27
ZX108
NOMESCO Finland
Inhalation
9.4
27.9
58
63
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.9
27.7
70
104
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.0
27.6
69
101
C03DA01
ATC
spironolactone; oral
2.2
27.1
294
1418
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
26.8
404
2236
D73.1
ICD-10 Finland
Hypersplenism
76.0
26.8
30
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
7.4
26.7
64
88
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.1
26.6
106
266
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
29.6
26.3
35
12
ED1AA
NOMESCO Finland
Mandipular X-ray examination
12.6
25.8
46
37
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
25.8
211
883
L04AX01
ATC
azathioprine; systemic
3.4
25.7
130
399
JMA10
NOMESCO Finland
Transabdominal total splenectomy
16.0
25.4
41
26
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
12.7
25.3
45
36
N02AX02
ATC
tramadol; systemic, rectal
1.6
25.1
951
6975
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
8.2
24.9
56
70
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.6
24.8
87
193
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
24.5
436
2554
B02AA02
ATC
tranexamic acid; systemic
2.1
24.1
313
1629
B01AB05
ATC
enoxaparin; parenteral
1.7
24.0
695
4732
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
23.9
251
1190
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
10.6
23.8
46
44
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
19.7
23.4
35
18
H02AB09
ATC
hydrocortisone; systemic
4.3
23.3
88
210
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.5
23.3
114
341
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
47.1
23.3
28
6
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
23.3
272
1353
J01DB01
ATC
cefalexin; oral
1.6
23.0
1844
16085
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
30.3
22.8
30
10
A07AA11
ATC
rifaximin; oral
40.5
22.7
28
7
122
Kela drug reimbursment
Aplastic anaemia
121.1
22.6
24
*
L04AD01
ATC
ciclosporin; systemic
4.8
22.4
75
159
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.4
22.2
67
126
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.8
22.1
74
157
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
22.0
128
436
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
6.1
22.0
60
100
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.3
21.8
83
200
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
221.8
21.6
22
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
21.2
342
1931
127
Kela drug reimbursment
Transplant complication
5.7
21.2
61
109
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
21.0
270
1397
J05AB11
ATC
valaciclovir; oral
2.0
20.9
303
1641
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
20.9
217
1022
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.6
20.9
155
613
B02BX04
ATC
romiplostim; parenteral
+∞
20.9
20
*
ZX131
NOMESCO Finland
Intrathecal
111.0
20.6
22
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
13.8
20.0
34
25
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
19.0
19.9
30
16
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
58.0
19.9
23
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
15.4
19.7
32
21
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.9
19.7
55
95
UJF32
NOMESCO Finland
Coloscopy
1.6
19.5
577
3915
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.9
19.4
118
414
K72.9
ICD-10 Finland
Hepatic failure, unspecified
10.7
19.4
37
35
TPX15
NOMESCO Finland
Removal of vascular injection port
15.7
19.3
31
20
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
13.4
19.2
33
25
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
19.1
184
836
TK800
NOMESCO Finland
Hemodialysis
4.1
18.9
75
189
K92.1
ICD-10 Finland
Melaena
2.6
18.9
145
584
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
18.8
164
711
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
13.5
18.7
32
24
A02BC01
ATC
omeprazole; systemic
1.6
18.7
627
4385
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.0
18.6
51
86
L04AA06
ATC
mycophenolic acid; systemic
4.9
18.4
60
124
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
15.2
18.4
30
20
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
18.4
605
4207
A41.8
ICD-10 Finland
Other specified sepsis
4.7
18.2
62
135
A05AA02
ATC
ursodeoxycholic acid; oral
5.2
17.7
55
108
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
8.2
17.7
39
48
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
17.5
156
683
J01MA14
ATC
moxifloxacin; systemic
2.0
17.4
221
1135
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
17.4
863
6575
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.6
17.3
78
220
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
24.2
17.3
24
10
A46
ICD-10 Finland
Erysipelas
1.8
17.3
325
1923
JN4CD
NOMESCO Finland
Very extensive body CT
2.8
17.2
113
415
N05CF01
ATC
zopiclone; oral
1.5
16.8
701
5139
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
35.3
16.7
21
6
WW200
NOMESCO Finland
Immunization
3.2
16.6
89
287
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.4
16.5
144
623
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
9.1
16.4
34
38
ZX112
NOMESCO Finland
Subcutaneous
3.6
16.4
75
215
N02BE01
ATC
paracetamol; systemic, rectal
1.5
16.2
1912
17239
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
7.1
16.1
39
56
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
16.0
183
899
R4110
NOMESCO Finland
Physiotherapy
1.5
16.0
582
4120
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
13.6
16.0
27
20
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
6.1
15.9
43
72
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
15.9
93
320
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
12.3
15.8
28
23
B01AA03
ATC
warfarin; systemic
1.6
15.8
472
3189
J01FF01
ATC
clindamycin; systemic
1.5
15.7
576
4084
D64.8
ICD-10 Finland
Other specified anaemias
4.3
15.7
58
138
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
15.6
352
2200
WX892
NOMESCO Finland
Monitored bed care
2.0
15.6
193
982
R60.0
ICD-10 Finland
Localized oedema
1.9
15.5
245
1363
TAB00
NOMESCO Finland
Lumbar puncture
2.7
15.4
108
416
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.3
15.3
40
64
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.8
15.3
98
356
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
20.2
15.1
22
11
A06AD11
ATC
lactulose; oral
1.7
15.1
339
2115
C91.4
ICD-10 Finland
Hairy-cell leukaemia
45.3
15.1
18
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
6.3
14.9
39
63
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
14.7
91
325
3038
Kela drug reimbursment
NA
+∞
14.6
14
*
1516
Kela drug reimbursment
NA
+∞
14.6
14
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
14.5
1061
8629
WX002
NOMESCO Finland
Sedation and analgesia
1.6
14.3
430
2900
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
14.3
129
568
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.6
14.3
65
186
R53
ICD-10 Finland
Malaise and fatigue
1.6
14.3
431
2910
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
13.4
14.2
24
18
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
5.5
14.2
41
75
L01BB02
ATC
mercaptopurine; oral
6.0
14.1
38
64
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
14.0
113
470
P01BA02
ATC
hydroxychloroquine; oral
2.0
14.0
174
884
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
17.6
13.8
21
12
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
53.6
13.8
16
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
53.6
13.8
16
*
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
5.4
13.6
40
75
WX110
NOMESCO Finland
Local anesthesy
1.4
13.5
1446
12517
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.0
13.4
42
85
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.6
13.3
94
364
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
5.2
13.2
40
78
J01MA02
ATC
ciprofloxacin; systemic
1.4
13.1
829
6535
SPAT1088
SPAT
Blood transfusion
8.3
13.0
28
34
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
16.8
13.0
20
12
N19
ICD-10 Finland
Unspecified kidney failure
2.6
12.9
92
359
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
50.3
12.8
15
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
12.8
151
754
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
11.6
12.8
23
20
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.4
12.8
45
103
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
6.2
12.6
33
54
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.1
12.6
48
119
WX882
NOMESCO Finland
High dependency care
2.8
12.5
78
281
C82.1
ICD-10 Finland
Follicular lymphoma grade II
6.7
12.5
31
47
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
8.7
12.5
26
30
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.7
12.4
54
150
K70.1
ICD-10 Finland
Alcoholic hepatitis
6.9
12.4
30
44
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
11.7
12.3
22
19
J01CA04
ATC
amoxicillin; systemic
1.4
12.2
1744
15706
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
12.2
418
2897
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
37.7
12.2
15
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.4
12.1
31
49
TGD00
NOMESCO Finland
Needle biopsy of lung
7.0
12.1
29
42
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.6
12.0
53
149
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
18.1
12.0
18
10
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
18.1
12.0
18
10
K72.1
ICD-10 Finland
Chronic hepatic failure
21.4
12.0
17
8
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.4
11.9
102
438
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
5.8
11.9
33
58
A07AA09
ATC
vancomycin; oral
4.3
11.8
43
102
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.3
11.8
107
474
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.2
11.8
125
597
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.6
11.7
40
89
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.6
11.7
82
317
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
11.6
710
5530
N03AX16
ATC
pregabalin; oral
1.5
11.6
468
3364
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
11.6
500
3643
K29.6
ICD-10 Finland
Other gastritis
4.5
11.5
40
91
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
2.7
11.5
80
308
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
9.3
11.5
23
25
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.8
11.5
72
261
K92.0
ICD-10 Finland
Haematemesis
2.8
11.5
72
261
28710
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia essentialis (Morbus Werlhof)
+∞
11.5
11
*
D68.0
ICD-10 Finland
Von Willebrand disease
+∞
11.5
11
*
K70.4
ICD-10 Finland
Alcoholic hepatic failure
7.5
11.4
26
35
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.1
11.4
127
620
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.4
11.4
29
46
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.3
11.3
41
97
J02AC03
ATC
voriconazole; systemic
11.8
11.3
20
17
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.8
11.3
185
1045
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.7
11.3
78
298
D68.9
ICD-10 Finland
Coagulation defect, unspecified
35.2
11.3
14
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
11.2
288
1858
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.2
11.2
29
47
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
20.1
11.1
16
8
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
20.1
11.1
16
8
WX872
NOMESCO Finland
Intensive care
2.1
11.1
118
566
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
11.1
269
1709
I81
ICD-10 Finland
Portal vein thrombosis
10.1
11.0
21
21
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
13.9
11.0
18
13
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
7.4
10.9
25
34
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
10.9
218
1310
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
6.3
10.9
28
45
M05BA04
ATC
alendronic acid; oral
1.9
10.9
162
884
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
10.8
73
277
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
7.2
10.7
25
35
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
10.7
226
1379
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
28.1
10.7
14
5
WW409
NOMESCO Finland
Other aferesis
17.9
10.7
16
9
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
17.9
10.7
16
9
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
21.5
10.7
15
7
K76.9
ICD-10 Finland
Liver disease, unspecified
3.9
10.7
43
113
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
12.9
10.6
18
14
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
10.6
160
880
M10.9
ICD-10 Finland
Gout, unspecified
1.9
10.6
152
820
Z94.4
ICD-10 Finland
Liver transplant status
9.2
10.5
21
23
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
10.5
358
2478
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
7.3
10.5
24
33
N03AX14
ATC
levetiracetam; systemic
2.8
10.4
65
234
B34.9
ICD-10 Finland
Viral infection, unspecified
2.7
10.4
69
258
E0000UV
ATC
NA
1.4
10.4
794
6402
130
Kela drug reimbursment
Malignant tumour
1.8
10.3
182
1053
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
10.2
361
2513
6753
FHL
Transabdominal splenectomy
23.4
10.2
14
6
C90.0
ICD-10 Finland
Multiple myeloma
4.1
10.2
38
93
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.3
10.2
36
84
WX402
NOMESCO Finland
General anaesthesia
1.5
10.1
329
2250
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
10.1
195
1159
J05AB01
ATC
aciclovir; systemic
1.5
10.1
404
2890
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.0
10.0
55
184
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
10.0
188
1109
212
Kela drug reimbursment
Gout
2.9
10.0
59
207
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
9.2
10.0
20
22
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
9.2
10.0
20
22
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
5.1
10.0
30
59
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.8
9.9
32
68
R31
ICD-10 Finland
Unspecified haematuria
1.7
9.9
225
1405
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
7.6
9.9
22
29
B02.9
ICD-10 Finland
Zoster without complication
2.0
9.9
122
621
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
9.8
152
842
A28
ICPC
Limited function/disability NOS
1.5
9.8
317
2165
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
20.1
9.8
14
7
JJC00
NOMESCO Finland
Allogenic transplantation of liver
10.7
9.8
18
17
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.6
9.8
69
268
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.0
9.7
53
178
R11
ICD-10 Finland
Nausea and vomiting
1.8
9.7
165
944
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
55.2
9.6
11
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
9.6
280
1866
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
11.4
9.6
17
15
C07AG02
ATC
carvedilol; oral
1.9
9.5
132
702
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
9.5
120
617
S97
ICPC
Chronic ulcer skin
2.0
9.5
117
596
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.5
9.5
71
286
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
3.5
9.4
43
126
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
100.4
9.4
10
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
100.4
9.4
10
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
21.8
9.3
13
6
ZX121
NOMESCO Finland
Central venous catheter
8.1
9.3
20
25
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
9.3
549
4224
P01AB01
ATC
metronidazole; oral, rectal
1.3
9.3
753
6101
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.2
9.1
87
399
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.2
9.1
91
424
B28
ICPC
Limited function/disability (B)
8.3
9.1
19
23
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
8.3
9.1
19
23
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.6
9.0
39
110
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
36.8
9.0
11
*
K76.6
ICD-10 Finland
Portal hypertension
36.8
9.0
11
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.9
8.9
52
181
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
8.9
146
825
E87.5
ICD-10 Finland
Hyperkalaemia
3.1
8.9
47
155
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.2
8.8
44
139
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
8.8
94
452
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.7
8.7
57
215
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
8.7
717
5812
WF002
NOMESCO Finland
Radical radiotherapy
1.9
8.7
115
604
ZX080
NOMESCO Finland
Image guided radiotherapy
2.9
8.7
51
180
WNF00
NOMESCO Finland
Infection source and contact determination
6.6
8.6
21
32
SPAT1262
SPAT
Handing over of treatment supplies
1.4
8.6
379
2758
M35.1
ICD-10 Finland
Other overlap syndromes
6.2
8.6
22
36
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
11.6
8.6
15
13
D07AC01
ATC
betamethasone; topical
1.3
8.6
662
5313
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
16.3
8.5
13
8
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.9
8.5
130
718
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
9.0
8.5
17
19
D69.8
ICD-10 Finland
Other specified haemorrhagic conditions
27.6
8.5
11
*
Z01.7
ICD-10 Finland
Laboratory examination
1.6
8.5
209
1334
D70.81
ICD-10 Finland
Neutropenia congenital
90.3
8.4
9
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
90.3
8.4
9
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
8.4
189
1177
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.8
8.4
136
769
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
8.3
110
575
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
9.5
8.3
16
17
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.0
8.2
47
161
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
8.1
82
386
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.8
8.1
49
177
306
Kela drug reimbursment
Erythropoietin and darbepoetin
8.1
8.1
17
21
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
33.4
8.1
10
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
8.1
211
1369
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
8.0
158
948
UKC02
NOMESCO Finland
Cystoscopy
1.4
8.0
345
2497
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
8.9
8.0
16
18
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
8.0
588
4673
A03
ICPC
Fever
1.5
8.0
293
2053
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.4
8.0
62
257
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.9
8.0
46
160
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
4.0
7.9
30
76
SPAT1255
SPAT
Intravenous administration of medicine
1.8
7.9
141
819
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
3.8
7.9
32
86
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
7.9
95
483
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
4.9
7.9
24
49
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.1
7.9
40
129
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
4.1
7.9
29
72
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
7.9
796
6626
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.9
7.8
105
556
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
6.1
7.8
20
33
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
10.8
7.8
14
13
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.4
7.8
35
103
B82
ICPC
Anaemia other/unspecified
2.5
7.8
57
228
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
7.7
342
2490
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
7.7
153
921
K29.7
ICD-10 Finland
Gastritis, unspecified
2.2
7.6
76
354
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.9
7.6
44
153
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.3
7.6
69
311
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
18.4
7.6
11
6
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
7.6
42
144
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
7.6
74
345
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
25.1
7.6
10
*
E87.6
ICD-10 Finland
Hypokalaemia
2.4
7.6
59
245
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.6
7.5
52
202
A04AD12
ATC
aprepitant; systemic
2.9
7.5
43
148
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
1.9
7.4
97
508
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.3
7.4
64
280
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
6.5
7.4
18
28
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
2.8
7.4
45
164
WF004
NOMESCO Finland
Palliative radiotherapy
2.7
7.4
48
181
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
13.4
7.4
12
9
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
7.4
292
2079
J01AA02
ATC
doxycycline; systemic
1.3
7.4
1632
14964
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.0
7.3
39
131
28799
ICD-8 Finland
Purpura and other haemorrhagic conditions, Other and unspecified
+∞
7.3
7
*
D61.8
ICD-10 Finland
Other specified aplastic anaemias
+∞
7.3
7
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
7.3
7
*
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
7.3
7
*
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
+∞
7.3
7
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.6
7.3
31
88
C07AB07
ATC
bisoprolol; oral
1.3
7.2
968
8332
K70.0
ICD-10 Finland
Alcoholic fatty liver
5.2
7.2
21
41
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
15.8
7.2
11
7
I50.0
ICD-10 Finland
Congestive heart failure
1.7
7.2
150
916
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
7.2
138
822
N05BA04
ATC
oxazepam; oral
1.4
7.2
464
3605
TKC20
NOMESCO Finland
Catheterisation of bladder
1.7
7.2
153
941
3AC01
NOMESCO Finland
NA
3.8
7.1
28
74
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
20.1
7.1
10
5
R06.0
ICD-10 Finland
Dyspnoea
1.3
7.1
485
3802
SPAT1263
SPAT
Sampling
1.3
7.1
850
7210
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
5.0
7.1
21
42
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
7.0
126
739
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
7.0
456
3552
WX730
NOMESCO Finland
Conventional respirator
2.9
7.0
40
139
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
6.9
118
680
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
3.1
6.9
35
114
B73
ICPC
Leukaemia
13.8
6.9
11
8
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
2.9
6.9
40
141
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
6.8
164
1039
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
6.8
211
1426
TJA10
NOMESCO Finland
Laparocentesis
8.3
6.8
14
17
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.2
6.8
33
104
K76.7
ICD-10 Finland
Hepatorenal syndrome
11.0
6.8
12
11
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.7
6.7
44
167
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
6.7
107
600
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.4
6.7
55
237
A10AE04
ATC
insulin glargine; parenteral
1.6
6.7
183
1200
Z31.5
ICD-10 Finland
Genetic counselling
1.9
6.7
89
469
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
6.7
887
7606
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
3.0
6.7
35
117
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.4
6.6
54
232
A02BC05
ATC
esomeprazole; systemic
1.3
6.6
775
6543
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
6.6
223
1535
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.6
154
973
318
Kela drug reimbursment
Teriparatide
5.9
6.6
17
29
B99
ICPC
Blood/lymph/spleen disease other
5.5
6.6
18
33
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.4
6.6
51
214
ZX100
NOMESCO Finland
Oral
3.0
6.6
35
118
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.9
6.6
98
539
D53.1
ICD-10 Finland
Other megaloblastic anaemias, not elsewhere classified
10.0
6.5
12
12
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.4
6.5
52
220
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
6.4
77
392
D59.5
ICD-10 Finland
Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
70.0
6.4
7
*
126
Kela drug reimbursment
Chronic coagulation defects
70.0
6.4
7
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
14.3
6.4
10
7
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
6.4
93
509
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.4
406
3144
I50
ICD-10 Finland
Heart failure
2.1
6.4
67
322
A98.5
ICD-10 Finland
Haemorrhagic fever with renal syndrome
2.5
6.3
45
180
L01AA01
ATC
cyclophosphamide; systemic
5.2
6.3
18
35
ZXA00
NOMESCO Finland
Right side
1.3
6.3
516
4150
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.8
6.3
96
536
M32
ICD-10 Finland
Systemic lupus erythematosus
18.1
6.3
9
5
B72
ICPC
Hodgkin Lymphoma
18.1
6.3
9
5
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
18.1
6.3
9
5
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.4
6.2
48
202
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.3
6.2
53
232
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.2
6.2
29
90
A10AE05
ATC
insulin detemir; parenteral
1.8
6.1
106
615
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
6.1
450
3562
B01AB04
ATC
dalteparin; parenteral
1.8
6.1
97
548
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.2
6.1
30
96
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.5
6.1
44
178
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
6.1
170
1126
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.8
6.0
36
131
L01XX05
ATC
hydroxycarbamide; oral
3.0
6.0
31
103
SPAT1234
SPAT
Support of social functional capacity
1.8
6.0
99
563
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
6.0
368
2833
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
385
429
10.32
321.77
6.7
5.0
4502.8
810.9
iu/ml
0.46
57
55
664
1249
6.75
307.65
2.2
1.8
1.2
1.4
g/l
1.68
625
1135
785
1589
6.59
307.65
3.7
2.7
10.0
10.5
g/l
1.51
735
1451
949
1909
7.17
307.65
5.3
2.5
77.0
69.5
e9/l
2.80
740
1446
1168
2482
7.60
307.65
7.6
3.9
275.7
245.8
u/l
3.11
1125
2346
619
339
23.48
307.65
2.0
1.5
—
—
—
0
0
1161
2564
7.25
307.65
5.1
2.5
1.9
1.8
%
3.59
1076
2265
467
526
10.55
307.65
2.4
1.5
—
—
—
0
0
436
603
8.45
306.62
3.6
2.7
3.3
3.6
g/l
3.35
419
572
559
1017
6.69
305.45
2.5
1.8
1.2
1.5
g/l
11.52
471
881
1905
10108
4.11
246.27
13.4
5.8
2.4
2.9
%
17.90
1841
9394
1910
10155
4.11
246.12
13.9
6.1
9.7
8.7
%
17.26
1844
9487
1928
10419
4.08
239.96
13.5
6.0
27.5
27.6
%
0.13
1865
9697
292
331
9.78
239.31
3.4
3.2
22715.8
1923.7
u/ml
0.50
26
22
961
3350
3.92
232.64
3.5
2.0
30.3
29.9
s
1.21
932
3244
197
126
16.80
231.38
2.7
2.4
—
—
—
0
0
209
157
14.36
224.82
3.0
2.3
31.2
45.7
%
2.14
16
22
199
137
15.62
224.75
2.8
2.4
13.8
13.6
%
0.04
58
64
1872
10251
3.78
220.44
12.4
5.8
56.4
57.4
%
2.51
1797
9580
1927
10758
3.86
220.02
12.3
5.6
0.0
0.0
e9/l
19.33
1761
9236
1963
11115
3.91
218.74
13.3
5.9
0.1
0.2
e9/l
33.58
1799
9696
969
3520
3.75
218.68
7.9
3.4
0.8
0.8
mmol/l
5.77
927
3303
607
1588
4.66
215.89
7.0
3.8
0.9
0.6
%
1.77
325
368
1943
11021
3.82
213.73
12.6
5.7
1.6
1.9
e9/l
11.21
1799
9648
278
352
8.70
208.31
5.8
3.3
1.5
1.5
%
0.02
235
270
129
55
24.60
181.08
2.5
2.4
—
—
—
0
0
2023
12492
3.57
178.80
24.3
8.6
3.5
4.2
e9/l
24.88
1877
10859
610
1827
4.03
178.55
2.8
2.7
65.4
66.4
g/l
1.86
567
1673
813
2977
3.49
175.91
3.2
2.6
25.7
22.8
%
4.32
752
2544
1884
11212
3.32
175.73
15.1
6.1
14.7
12.2
umol/l
5.40
1825
10634
261
392
7.27
168.03
2.6
1.7
—
—
—
0
0
833
3177
3.36
167.77
3.2
2.5
2.2
2.3
g/l
4.89
787
2940
333
646
5.75
166.17
3.6
2.5
87.4
89.8
%
0.81
327
614
298
531
6.19
162.48
2.6
1.6
—
—
—
0
0
865
3455
3.23
160.31
3.2
2.5
13.7
13.0
umol/l
1.63
825
3199
301
551
6.03
159.55
2.5
1.6
—
—
—
0
0
199
247
8.63
150.77
2.1
1.6
—
—
—
0
0
775
2994
3.24
150.73
9.4
6.0
1.1
1.0
mmol/l
0.66
735
2782
297
572
5.72
148.92
3.8
2.6
193.7
191.4
%
0.15
290
544
239
373
6.94
148.14
1.4
1.5
107.0
123.2
u/ml
0.52
41
59
926
4003
3.01
147.58
2.1
1.5
2.7
2.5
g/l
1.19
714
2395
219
316
7.46
145.85
2.0
1.5
—
—
—
0
0
1608
9343
2.82
144.97
9.2
4.9
33.5
35.3
g/l
24.03
1525
8669
139
113
12.92
142.02
2.3
1.7
—
—
—
0
0
139
113
12.92
142.02
2.3
1.7
—
—
—
0
0
245
413
6.43
140.83
1.3
1.3
—
—
—
0
0
1099
5425
2.75
133.83
8.1
4.0
82.5
88.1
%
9.22
1061
5290
582
2054
3.35
129.49
3.4
2.3
0.2
0.2
g/l
9.94
537
1918
224
379
6.36
128.07
1.9
1.4
—
—
—
0
0
238
428
6.01
127.89
6.0
3.5
56.5
57.8
%
0.56
238
428
1618
9860
2.63
125.48
12.3
6.3
1.2
1.2
mmol/l
3.97
1520
8896
1723
10837
2.67
124.93
13.6
7.0
1.2
1.2
mmol/l
2.84
1360
9131
196
297
7.04
124.55
1.9
1.5
—
—
—
0
0
138
136
10.65
124.18
1.6
1.3
—
—
—
0
0
222
389
6.13
122.43
1.3
1.3
285.1
260.2
u/ml
0.43
149
225
138
145
9.98
118.59
2.0
1.4
—
—
—
0
0
129
125
10.79
117.41
2.1
1.5
—
—
—
0
0
148
175
8.90
116.25
2.1
1.5
—
—
—
0
0
472
1558
3.47
115.97
2.5
1.6
—
—
—
0
0
128
125
10.71
115.86
2.1
1.5
—
—
—
0
0
616
2412
3.02
113.47
5.8
2.8
12.7
8.7
umol/l
2.64
556
2110
816
3714
2.73
113.26
2.8
1.8
—
—
—
0
0
181
293
6.55
107.83
2.0
1.4
—
—
—
0
0
1071
5666
2.49
107.70
5.0
2.8
2209.2
6045.5
umol/l
3.42
977
4892
1466
8928
2.43
107.61
15.0
9.8
1.3
1.3
inr
0.71
549
2515
193
337
6.10
106.60
1.9
1.4
—
—
—
0
0
232
482
5.18
106.12
5.9
2.9
40.7
36.8
umol/l
0.77
203
409
1524
9501
2.41
105.24
25.3
9.4
0.0
0.0
e9/l
2.00
1307
7711
1470
9116
2.37
101.37
4.1
2.8
350.0
131.1
ug/l
10.69
1385
8380
1051
5657
2.42
100.08
2.8
2.2
3.4
3.0
mg/l
4.83
940
4796
142
192
7.76
99.71
1.5
1.2
—
—
—
0
0
527
2053
2.95
96.61
11.3
7.4
10.5
10.1
mmol/l
0.53
502
1950
102
98
10.78
93.24
5.1
3.0
—
—
—
0
0
266
685
4.20
92.95
2.9
3.5
2.3
1.8
ratio
0.23
12
54
271
708
4.15
92.88
3.0
3.5
253.2
59.4
mg/l
0.48
205
571
270
709
4.12
91.87
3.0
3.5
33.9
80.0
mg/l
1.54
204
572
598
2574
2.71
90.17
2.3
1.7
—
—
—
0
0
598
2586
2.69
89.25
2.3
1.8
—
—
—
0
0
235
568
4.44
89.15
2.7
1.5
0.2
0.2
g/l
7.44
212
543
1150
6700
2.26
88.25
4.2
3.4
136.5
82.4
e6/l
0.73
961
5196
951
5135
2.32
87.38
1.8
1.6
18.4
20.4
nmol/l
4.38
867
4368
244
617
4.25
87.23
2.2
1.7
—
—
—
0
0
122
163
7.80
86.46
1.7
1.6
—
—
—
0
0
457
1752
2.94
85.49
10.8
3.7
1.2
1.2
mmol/l
1.84
427
1511
236
591
4.28
85.42
2.7
1.5
1.1
1.2
g/l
4.75
219
564
113
140
8.38
85.31
3.7
2.2
562.2
524.3
e6/l
0.17
82
117
204
459
4.73
84.57
1.7
1.4
—
—
—
0
0
2158
16531
2.61
82.98
18.2
7.3
88.5
79.8
u/l
9.15
2093
15543
1524
10120
2.18
82.33
9.2
4.1
—
—
—
0
0
1060
6124
2.21
81.41
4.1
3.3
0.5
0.4
e6/l
0.43
870
4667
306
950
3.51
81.38
2.5
1.9
2.5
2.1
ug/l
0.15
282
838
1252
7745
2.16
80.61
5.0
3.8
120.7
108.0
e6/l
0.12
994
5559
805
4182
2.33
79.66
2.1
1.8
1261.3
1171.0
nmol/l
1.69
643
3146
256
721
3.82
78.67
2.0
2.6
0.9
1.2
g/l
0.40
207
630
280
848
3.57
77.23
2.0
2.5
6.6
7.4
g/l
10.73
205
644
280
848
3.57
77.23
2.0
2.5
—
—
—
0
0
279
847
3.56
76.66
2.0
2.5
3.6
3.8
g/l
1.12
196
617
225
589
4.08
76.57
1.3
1.3
—
—
—
0
0
1784
12809
2.19
76.23
9.8
4.9
6.7
6.8
mmol/l
0.95
1727
12000
108
146
7.67
75.71
3.7
2.1
470.8
689.0
e6/l
1.75
40
65
103
133
8.02
75.09
4.0
2.3
0.2
0.2
e9/l
0.02
81
116
153
298
5.39
74.93
1.5
1.2
7.8
3.7
u/ml
0.63
73
103
846
4596
2.23
74.32
2.7
1.7
1.9
1.2
mg/l
6.42
703
3517
227
622
3.90
72.42
7.3
4.9
1.7
1.5
mg/l
0.81
211
569
89
102
8.99
71.42
2.6
3.4
83.9
93.8
%
1.23
84
97
260
793
3.53
70.77
2.1
2.6
3.1
3.1
g/l
0.23
199
631
164
362
4.76
69.42
1.5
1.2
113.2
37.9
u/l
3.70
151
314
512
2295
2.52
69.36
6.6
3.4
—
—
—
0
0
224
628
3.80
69.09
2.0
2.5
0.0
0.0
g/l
0.00
195
584
104
150
7.17
68.81
1.1
1.3
—
—
—
0
0
257
795
3.47
68.38
1.9
2.5
10.9
10.3
g/l
1.01
218
678
108
166
6.74
67.37
1.5
2.0
5.0
4.7
mg/l
0.13
101
159
370
1437
2.83
66.61
9.3
8.7
24.1
24.9
mmol/l
4.00
364
1430
1105
6872
2.04
66.46
6.1
3.2
40.1
36.7
u/l
0.57
1051
6534
213
597
3.79
65.66
2.0
2.4
0.0
0.0
g/l
0.50
184
555
831
4670
2.13
65.53
3.4
2.6
6.4
5.4
e6/l
0.90
769
4121
1330
8877
2.00
65.04
2.4
2.0
90.9
94.2
pmol/l
1.77
820
4669
451
1965
2.56
64.50
2.2
2.1
350.9
371.6
nmol/l
1.30
430
1799
1075
6705
2.01
63.33
3.7
2.6
54.7
57.8
u/l
1.14
990
6181
66
61
11.07
61.81
1.3
1.4
—
—
—
0
0
205
592
3.67
60.41
2.0
2.4
0.0
0.0
g/l
0.00
184
554
133
285
4.86
58.26
1.5
1.2
5.2
3.8
u/ml
0.66
81
125
216
661
3.47
58.24
2.0
2.4
37.0
37.6
g/l
0.60
186
576
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
237
771
3.28
57.96
3.9
2.9
0.3
0.4
u/ml
3.59
146
431
118
231
5.30
57.36
6.3
3.2
53.7
58.2
%
0.95
80
150
183
507
3.80
57.25
5.5
4.8
2.2
2.7
mmol/l
1.54
127
345
183
508
3.79
57.08
5.6
4.8
4.7
5.1
kpa
8.40
177
502
123
252
5.07
56.78
3.0
1.6
—
—
—
0
0
881
5292
1.99
56.28
5.3
2.3
—
—
—
0
0
210
648
3.43
55.85
1.8
1.2
—
—
—
0
0
1846
14207
1.97
55.27
6.0
4.5
90.8
1505.0
e6/l
2.38
48
215
65
70
9.49
54.63
3.0
2.3
32.2
27.7
%
1.15
59
65
1986
15707
2.04
54.58
6.0
4.0
16.9
12.4
mm/h
19.57
1875
14490
231
769
3.19
54.30
2.6
2.7
—
—
—
0
0
167
461
3.80
52.47
3.6
2.5
14.7
16.0
%
3.01
86
236
1100
7260
1.88
51.97
4.9
3.3
2.3
2.4
mmol/l
7.11
983
6311
110
225
5.06
50.85
3.2
1.7
—
—
—
0
0
51
43
12.07
50.64
1.5
1.1
—
—
—
0
0
321
1351
2.56
48.59
1.8
1.5
—
—
—
0
0
33
13
25.69
47.14
1.2
1.1
—
—
—
0
0
125
304
4.27
46.70
7.4
6.4
11.5
11.9
mg/l
0.41
118
282
285
1162
2.63
45.94
8.0
4.4
24.1
24.0
mmol/l
0.24
265
1050
442
2213
2.20
44.84
7.1
4.1
5.7
5.8
kpa
2.31
426
2143
132
347
3.95
44.39
1.2
1.1
—
—
—
0
0
439
2204
2.19
44.18
7.2
4.1
1.5
1.9
mmol/l
1.46
370
1743
133
355
3.89
43.78
2.7
2.0
2.0
1.7
mmol/l
1.91
128
348
30
12
25.27
42.56
1.2
1.6
—
—
—
0
0
66
98
6.88
42.48
31.4
27.5
140.8
123.0
ug/l
0.94
58
79
1401
10381
1.74
41.71
6.4
5.0
0.0
0.0
estimate
0.50
435
1983
1399
10382
1.73
41.24
4.9
3.6
0.0
0.0
estimate
0.00
431
1941
54
66
8.33
41.11
1.1
1.2
—
—
—
0
0
1411
10507
1.73
40.98
5.0
3.7
0.0
0.0
estimate
0.12
419
1905
76
136
5.72
40.70
2.9
1.6
—
—
—
0
0
72
124
5.94
40.12
3.2
2.7
32.9
39.7
%
0.92
24
40
36
25
14.58
39.96
1.1
1.0
—
—
—
0
0
82
161
5.22
39.71
1.4
1.2
—
—
—
0
0
955
6431
1.76
39.33
4.0
3.1
2085.9
1544.7
ng/l
2.66
860
5516
47
51
9.36
39.24
1.5
1.2
—
—
—
0
0
54
72
7.63
38.24
1.2
1.4
—
—
—
0
0
599
3541
1.89
37.68
3.7
3.0
2.3
2.1
e6/l
0.28
357
1967
84
177
4.87
37.50
1.1
1.0
—
—
—
0
0
61
96
6.48
37.17
1.3
1.2
—
—
—
0
0
315
1479
2.28
36.97
6.5
4.5
1.8
1.7
mmol/l
0.29
240
1090
326
1556
2.25
36.78
6.4
4.6
5.0
5.1
kpa
1.81
307
1448
57
85
6.83
36.54
3.1
3.5
65.3
61.9
mg/l
0.17
51
63
28
14
20.20
36.34
2.4
5.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
36
30
12.15
35.93
1.3
1.0
67.9
68.0
%
—
12
6
175
630
2.90
35.65
6.4
5.1
8.2
8.3
kpa
0.34
161
583
159
543
3.05
35.58
1.9
2.0
10.5
11.7
mg/l
0.90
151
496
44
50
8.93
35.46
1.3
1.1
78.3
83.6
%
0.32
24
28
37
33
11.36
35.37
1.8
2.7
—
—
—
0
0
25
10
25.23
35.36
1.2
1.1
—
—
—
0
0
730
4665
1.78
35.31
1.9
1.7
474.8
24715154.9
pmol/l
3.29
617
3856
166
590
2.93
34.60
5.6
3.3
24.0
24.8
mmol/l
1.35
150
514
53
78
6.91
34.39
1.8
2.3
350.0
34635.1
u/ml
—
6
14
1143
8303
1.66
34.25
5.6
3.8
45.7
55.1
ng/l
0.49
934
5893
187
715
2.74
34.01
1.7
1.5
448.9
249.7
titre
—
9
31
381
1992
2.06
33.90
9.6
7.4
1.5
1.4
mmol/l
1.32
368
1917
43
52
8.39
33.00
1.2
1.0
82.2
83.6
%
0.08
22
29
158
563
2.92
32.77
1.4
1.3
21.3
18.0
iu/ml
—
7
10
86
206
4.28
32.77
4.1
2.6
—
—
—
0
0
34
30
11.47
32.71
1.3
1.1
62.1
82.0
%
—
12
7
834
5637
1.70
32.52
5.3
4.0
0.0
0.0
estimate
1.28
398
1891
1168
8615
1.63
32.37
2.7
2.2
75.6
77.0
nmol/l
0.90
1060
7664
498
2904
1.88
32.14
24.0
26.6
1.5
1.4
inr
0.51
53
423
485
2807
1.89
32.03
10.2
7.0
104.5
104.4
mmol/l
0.25
468
2742
353
1831
2.07
31.99
6.6
3.6
4.7
4.6
kpa
0.35
338
1770
103
287
3.69
31.87
1.2
1.1
1.6
1.5
g/l
0.63
97
261
165
613
2.80
31.68
2.7
1.8
—
—
—
0
0
83
201
4.23
31.19
3.6
1.6
—
—
—
0
0
83
201
4.23
31.19
3.6
1.6
—
—
—
0
0
83
201
4.23
31.19
3.6
1.6
—
—
—
0
0
58
104
5.68
31.01
1.4
1.2
—
—
—
0
0
629
3979
1.76
30.89
3.9
3.0
2.5
2.5
mmol/l
0.80
556
3485
183
729
2.62
30.66
1.4
1.2
1.1
0.7
u/ml
—
6
61
370
1991
2.00
30.19
3.1
2.4
31.4
62.7
u/l
0.71
318
1696
73
164
4.55
30.18
1.3
1.2
300.0
168.8
titre
0.40
12
25
38
44
8.75
30.17
1.8
1.2
—
—
—
0
0
601
3776
1.76
30.13
3.5
2.9
1.2
1.1
e6/l
0.39
362
2194
44
62
7.20
29.69
1.9
1.5
9.4
12.6
g/l
1.19
27
47
45
68
6.71
28.50
3.1
1.9
4160.9
24836.8
e6/l
0.44
33
46
34
38
9.05
27.72
1.4
1.3
—
—
—
0
0
438
2570
1.84
27.34
9.7
7.6
0.9
1.1
mmol/l
0.29
341
2006
50
88
5.77
27.27
4.8
1.9
—
—
—
0
0
50
88
5.77
27.27
4.8
1.9
—
—
—
0
0
2365
21310
1.98
27.16
37.8
14.7
24.0
25.0
mg/l
0.79
2140
16965
50
90
5.64
26.64
4.8
1.9
—
—
—
0
0
436
2575
1.83
26.59
9.6
7.6
4.9
5.1
kpa
2.58
415
2455
47
80
5.96
26.52
3.1
2.3
374.4
803.9
e6/l
1.44
41
67
435
2576
1.82
26.27
9.6
7.6
12.5
12.1
kpa
0.71
414
2457
273
1384
2.08
26.09
2.1
1.6
—
—
—
0
0
76
197
3.94
26.09
2.3
1.4
28.7
28.0
iu/ml
—
10
13
57
118
4.91
26.02
1.1
1.0
—
—
—
0
0
56
115
4.95
25.80
4.4
1.8
—
—
—
0
0
56
115
4.95
25.80
4.4
1.8
—
—
—
0
0
56
115
4.95
25.80
4.4
1.8
—
—
—
0
0
56
115
4.95
25.80
4.4
1.8
—
—
—
0
0
904
6526
1.58
25.77
2.7
2.1
335.0
235.0
u/l
0.46
851
6125
1650
13614
1.56
25.77
5.4
3.1
71.5
50.7
u/l
11.54
1550
12628
133
494
2.78
25.54
3.0
2.2
115.1
128.7
g/l
6.67
111
363
33
42
7.94
24.28
1.4
1.4
—
—
—
0
0
34
45
7.64
24.21
1.4
1.4
14.5
25.2
g/l
2.98
27
35
41
67
6.20
24.10
5.3
2.2
—
—
—
0
0
379
2220
1.82
23.55
3.9
4.1
21.4
24.2
ug/l
0.10
314
1827
1051
7979
1.52
23.28
5.3
3.9
—
—
—
0
0
54
118
4.65
23.14
2.5
1.3
—
—
—
0
0
46
89
5.24
22.69
2.7
1.4
—
—
—
0
0
46
89
5.24
22.69
2.7
1.4
—
—
—
0
0
53
116
4.64
22.67
2.5
1.3
—
—
—
0
0
2010
17576
1.58
22.30
46.0
17.7
14.6
13.7
%
74.34
1987
17164
192
902
2.22
22.23
2.0
1.8
44.7
38.3
u/l
2.25
179
787
73
206
3.62
22.22
1.6
1.6
—
—
—
0
0
51
114
4.54
21.27
1.3
1.2
1.2
1.1
ratio
1.21
26
44
169
769
2.28
21.13
2.7
2.2
450.2
497.8
ug/l
0.11
156
720
394
2408
1.75
21.05
2.2
1.8
1.8
1.5
%
2.66
319
2109
63
167
3.84
21.00
1.1
1.0
291.0
286.4
mg/l
0.13
57
150
380
2311
1.75
20.63
10.5
8.0
95.3
95.5
%
0.18
364
2224
94
327
2.94
20.39
1.3
1.2
—
—
—
0
0
70
204
3.50
20.32
1.3
1.2
82.9
57.7
u/l
0.56
58
140
118
466
2.60
20.12
2.8
1.5
62.1
30.1
e6/l
0.26
99
361
118
466
2.60
20.12
2.9
1.6
364.7
748.2
e6/l
0.57
102
379
225
1190
1.97
18.99
11.1
10.0
24.0
24.2
mmol/l
0.73
214
1112
51
128
4.04
18.36
1.6
1.5
4.3
6.7
u/l
0.59
27
61
342
2113
1.71
17.39
11.4
8.5
112.9
121.8
g/l
11.02
330
2032
118
503
2.41
17.15
1.6
1.2
3.6
3.5
u/ml
0.01
16
42
99
389
2.60
17.08
1.6
1.2
54.6
47.3
u/ml
0.17
23
32
109
449
2.49
17.06
3.2
3.4
353.0
942.9
u/ml
0.47
96
417
119
511
2.39
17.02
1.6
1.2
20.6
8.8
u/ml
0.48
23
76
114
481
2.43
16.95
1.4
1.3
—
—
—
0
0
114
481
2.43
16.95
1.4
1.3
—
—
—
0
0
81
288
2.87
16.94
1.2
1.1
—
—
—
0
0
21
24
8.81
16.78
1.5
1.9
—
—
—
0
0
123
547
2.31
16.25
1.6
1.2
37.8
38.3
u/ml
0.01
13
24
277
1650
1.76
16.01
5.9
4.2
103.8
92.4
ng/l
1.04
242
1438
105
439
2.45
15.93
1.8
1.7
—
—
—
0
0
196
1053
1.93
15.78
6.3
2.9
1.2
1.2
%
0.15
196
1046
25
39
6.46
15.37
1.1
1.3
60.3
159.1
titre
—
6
7
79
295
2.73
15.10
1.6
1.5
29.8
32.4
g/l
1.11
71
266
14
10
14.07
15.05
1.4
1.5
—
—
—
0
0
24
37
6.54
14.92
2.3
1.1
—
—
—
0
0
30
58
5.22
14.85
1.4
1.2
28.0
15.3
%
—
6
10
155
785
2.03
14.77
3.6
3.3
551.4
5251.4
u/ml
0.74
130
675
614
4503
1.47
14.69
1.4
1.3
3.5
1.4
u/ml
1.41
143
1142
2354
21925
1.63
14.51
38.7
17.2
139.2
139.6
mmol/l
14.29
2320
21358
2358
21980
1.63
14.39
39.5
17.3
4.0
4.0
mmol/l
0.01
2318
21381
237
1391
1.77
14.38
6.1
3.4
116.6
128.5
g/l
10.71
232
1352
176
944
1.93
14.24
3.6
1.9
—
—
—
0
0
112
511
2.24
13.96
1.3
1.2
—
—
—
0
0
69
252
2.78
13.78
1.5
1.8
—
1253.3
—
0
9
130
636
2.10
13.61
1.5
1.6
1.8
10.9
iu/ml
0.45
32
125
580
4269
1.46
13.47
4.4
3.9
419.0
700.9
ng/l
0.60
470
3406
69
257
2.73
13.29
1.1
1.1
—
—
—
0
0
105
477
2.25
13.24
2.8
1.3
3.8
3.8
mmol/l
0.03
97
445
94
410
2.34
13.04
1.6
1.2
4.7
5.5
u/ml
—
5
27
100
451
2.26
12.84
2.9
1.4
—
—
—
0
0
127
630
2.07
12.83
1.4
1.4
260.2
281.0
ug/g
0.48
70
370
65
240
2.75
12.74
1.6
1.2
52.6
65.7
u/ml
—
5
10
13
11
11.87
12.64
1.1
1.0
—
—
—
0
0
52
174
3.03
12.19
1.4
1.4
—
—
—
0
0
39
109
3.62
12.15
1.3
1.1
27.0
32.2
u/l
0.28
32
80
358
2449
1.53
11.79
2.5
2.3
159.9
137.3
ug/g
0.51
292
1934
2143
19788
1.42
11.49
32.7
13.7
78.5
79.8
ml/min/173m2
1.67
1896
16303
69
279
2.51
11.33
1.2
1.1
107.1
115.2
%
0.94
62
255
113
565
2.04
11.21
1.3
1.3
199.3
234.8
miu/ml
0.41
40
247
15
6
25.12
11.13
1.0
1.0
—
—
—
0
0
1776
15953
1.34
11.00
4.2
3.8
14.8
14.8
pmol/l
0.20
1624
14411
42
134
3.17
10.70
1.7
1.9
—
—
—
0
0
15
7
21.54
10.67
1.1
1.0
—
—
—
0
0
153
862
1.82
10.66
2.3
1.8
—
—
—
0
0
172
1005
1.76
10.61
8.1
5.2
24.8
24.7
mmol/l
0.30
163
946
45
151
3.01
10.54
1.1
1.1
—
—
—
0
0
45
151
3.01
10.54
1.1
1.1
—
—
—
0
0
223
1403
1.64
10.47
9.9
7.1
24.8
24.5
mmol/l
0.42
204
1309
144
801
1.84
10.46
4.7
3.8
1.4
1.4
mmol/l
0.07
136
792
224
1414
1.64
10.38
12.1
9.3
1.5
1.3
%
1.08
219
1406
2089
19299
1.38
10.37
35.1
15.8
37.5
39.6
%
18.02
1409
13551
45
154
2.96
10.19
1.1
1.1
—
—
—
0
0
45
154
2.96
10.19
1.1
1.1
—
—
—
0
0
45
154
2.96
10.19
1.1
1.1
—
—
—
0
0
221
1408
1.62
9.87
12.5
9.5
0.7
0.7
%
0.74
216
1401
61
254
2.43
9.47
1.3
1.3
—
—
—
0
0
49
184
2.69
9.39
1.2
1.1
—
—
u/ml
—
0
0
66
286
2.34
9.38
1.2
1.1
—
—
—
0
0
61
256
2.42
9.31
3.7
1.4
—
—
—
0
0
116
628
1.89
9.20
1.3
1.1
—
—
—
0
0
61
258
2.40
9.16
3.7
1.4
—
—
—
0
0
115
622
1.89
9.15
1.3
1.1
—
—
—
0
0
36
116
3.13
9.07
1.6
1.6
2.0
2.5
u/field
0.23
27
84
61
260
2.38
9.01
3.7
1.4
—
—
—
0
0
11
12
9.20
8.98
1.7
1.5
1.9
5.7
mg/l
—
6
5
61
261
2.37
8.94
3.7
1.4
—
—
—
0
0
60
256
2.37
8.85
3.8
1.4
—
—
—
0
0
59
250
2.39
8.84
6.4
6.7
9.0
7.3
mmol/l
0.33
51
209
21
47
4.50
8.83
1.2
1.1
—
—
—
0
0
60
258
2.36
8.70
3.7
1.4
—
—
—
0
0
62
271
2.32
8.67
1.5
1.4
1222.4
1609.1
e6/l
0.66
50
192
33
105
3.17
8.50
1.2
1.4
—
—
—
0
0
13
19
6.87
8.44
1.1
1.1
—
—
—
0
0
46
178
2.61
8.35
2.1
2.2
767.0
614.1
ml
1.23
31
114
20
46
4.37
8.14
3.8
3.0
40.9
40.1
u/l
—
7
12
28
83
3.40
8.07
1.3
1.2
—
—
—
0
0
2365
22541
1.44
7.94
23.4
10.3
28.0
26.4
u/l
1.87
2313
21706
2362
22521
1.43
7.78
40.4
17.1
86.1
79.5
umol/l
8.28
2362
22511
55
241
2.31
7.69
1.5
1.4
49302.6
85624.6
e6/l
0.44
35
140
187
1220
1.57
7.59
15.6
10.6
—
—
—
0
0
10
12
8.36
7.58
3.8
4.2
—
—
—
0
0
191
1266
1.55
7.24
1.4
1.3
405.9
228.9
u/ml
1.09
167
1163
10
13
7.72
7.12
1.1
4.7
—
—
—
0
0
434
3365
1.35
7.01
1.3
1.2
42.9
35.9
iu/ml
0.26
128
1056
25
77
3.27
6.83
1.0
1.1
1100.7
1545.1
miu/ml
1.54
25
77
54
248
2.20
6.80
1.1
1.1
—
—
—
0
0
1436
12938
1.24
6.78
3.4
2.9
—
—
—
0
0
240
1703
1.45
6.55
3.3
2.8
58.5
65.0
ml/min/173m2
1.60
125
677
86
479
1.82
6.34
3.0
3.2
0.8
0.8
nmol/l
0.58
58
367
95
546
1.77
6.32
1.5
1.4
12.0
8.9
u/l
1.08
73
445
2050
19284
1.27
6.30
5.1
4.6
2.0
2.0
mu/l
0.02
1898
17553
266
1957
1.40
5.94
2.3
2.4
8.3
7.3
ug/l
0.38
233
1716
12
24
5.02
5.74
1.0
1.3
22.5
17.5
u/l
—
7
15
13
28
4.66
5.73
1.3
1.0
—
—
—
0
0
104
1647
0.62
5.56
2.0
1.7
—
—
—
0
0
14
34
4.13
5.36
1.9
1.6
4.7
7.4
%
—
9
16
787
6788
1.23
5.25
4.8
4.0
12.5
11.6
mg/mmol
0.11
532
4382
16
44
3.65
5.20
1.1
1.1
—
—
—
0
0
793
6874
1.22
5.00
4.0
3.2
7.2
7.6
mmol/l
1.99
669
5795
8
7
11.46
4.78
1.0
1.0
—
—
—
0
0
14
38
3.70
4.64
9.6
6.2
—
—
—
0
0
30
128
2.36
4.57
1.1
1.1
—
—
—
0
0
105
678
1.57
4.57
5.0
3.9
3.9
3.9
mmol/l
0.37
90
633
45
228
1.99
4.50
1.8
2.7
13.3
10.6
umol/l
0.29
34
158
132
915
1.47
4.15
6.6
3.2
84.7
51.8
u/ml
0.82
126
877
40
202
2.00
4.07
1.0
1.0
—
—
—
0
0
8
10
8.02
4.06
6.0
5.9
—
—
—
0
0
8
10
8.02
4.06
6.0
6.0
—
—
—
0
0
23
92
2.51
4.04
1.0
1.1
388.6
200.7
iu/ml
0.60
23
92
93
603
1.56
4.02
2.4
2.3
7637.0
3866.5
u/l
0.39
35
247
110
741
1.51
4.00
1.4
1.4
30.7
26.9
iu/l
0.46
88
621
99
657
1.53
3.87
1.7
1.7
—
—
—
0
0
250
1954
1.31
3.81
3.4
2.9
297.3
210.0
ng/l
2.08
232
1788
11
29
3.80
3.80
1.5
1.2
—
—
—
0
0
146
1050
1.41
3.80
1.3
1.3
—
—
—
0
0
32
153
2.10
3.78
2.2
1.5
1.1
1.2
promille
0.16
26
116
30
143
2.11
3.59
1.2
1.2
—
—
—
0
0
129
919
1.42
3.56
8.8
5.7
1.7
1.6
%
0.46
118
857
36
185
1.96
3.53
2.8
2.2
2.0
1.9
u/field
0.02
18
73
30
144
2.10
3.53
1.2
1.2
—
—
—
0
0
11
31
3.56
3.48
1.3
1.4
—
—
—
0
0
21
87
2.43
3.47
1.0
1.0
—
—
—
0
0
24
107
2.25
3.38
1.5
1.8
—
—
—
0
0
19
76
2.51
3.37
1.2
1.2
—
—
—
0
0
16
60
2.68
3.22
1.2
1.2
436.1
67.2
ug/l
—
9
27
23
103
2.24
3.22
3.5
3.7
—
—
—
0
0
11
33
3.34
3.19
7.5
4.2
46.2
41.0
umol/l
0.33
11
27
27
130
2.09
3.18
2.5
3.5
19.0
28.9
mu/l
0.59
27
123
19
80
2.38
3.06
1.2
1.1
—
—
—
0
0
85
577
1.49
3.05
1.3
1.4
—
—
—
0
0
2416
23594
1.26
2.98
56.5
21.4
162.0
247.8
e9/l
318.95
2370
22956
2418
23617
1.26
2.97
56.4
21.5
6.5
6.8
e9/l
2.17
2371
22905
2417
23608
1.26
2.95
56.4
21.4
4.2
4.5
e12/l
108.75
2369
22901
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
135
2.01
2.90
1.1
1.1
—
—
—
0
0
2417
23615
1.25
2.90
56.8
21.5
125.3
135.2
g/l
125.03
2391
23241
382
3247
1.21
2.84
1.3
1.2
15.1
12.1
u/ml
0.26
117
1239
40
231
1.74
2.80
3.6
3.8
—
—
—
0
0
15
61
2.47
2.62
1.6
1.4
9.9
8.9
ug/l
0.27
15
61
8
20
4.01
2.56
9.0
4.9
—
—
—
0
0
6
11
5.46
2.54
1.0
1.0
—
—
—
0
0
7
16
4.38
2.47
1.1
1.1
—
—
—
0
0
6
12
5.01
2.40
1.2
1.2
—
—
—
0
0
29
161
1.81
2.35
1.1
1.1
62.8
40.6
mg/l
1.02
19
134
6
13
4.62
2.27
1.3
1.4
—
—
—
0
0
73
517
1.42
2.20
1.6
1.7
21547.1
16053.4
e6/l
0.41
57
373
33
195
1.70
2.19
1.4
1.4
30.9
27.3
%
0.18
19
118
9
30
3.01
2.14
10.2
11.9
9.6
6.3
mmol/l
—
9
30
33
197
1.68
2.12
1.4
1.4
3.5
2.9
ug/l
0.46
27
174
32
520
0.61
2.09
1.3
1.4
—
—
—
0
0
5
10
5.01
2.07
2.4
2.9
—
—
—
0
0
18
89
2.03
2.05
1.2
1.1
2697.9
295.3
ng/l
—
7
20
26
147
1.78
2.02
2.6
1.5
0.9
1.0
g/l
0.72
26
147
76
558
1.37
1.90
1.4
1.3
—
—
—
0
0
67
488
1.38
1.78
4.6
3.6
30.7
28.3
mg/l
0.19
56
310
13
60
2.17
1.77
1.3
1.2
—
—
—
0
0
23
132
1.75
1.73
1.1
1.2
—
—
—
0
0
7
24
2.92
1.72
1.7
1.5
—
—
—
0
0
17
89
1.92
1.70
1.2
1.4
—
—
—
0
0
26
156
1.67
1.69
1.1
1.1
358.6
276.4
mg/l
0.61
20
136
507
4593
1.13
1.67
5.6
4.0
1.0
1.0
kg/l
0.11
86
693
73
551
1.33
1.58
2.8
2.3
186.7
105.0
ug/min
0.78
43
340
6
21
2.86
1.50
2.3
3.0
0.0
0.5
u/field
—
6
21
385
3454
1.13
1.49
1.6
1.5
—
—
—
0
0
15
80
1.88
1.44
2.0
2.3
212.2
118.5
ug/l
0.17
15
70
56
748
0.74
1.41
1.9
1.7
11.0
3.7
mg/l
0.89
41
520
15
81
1.86
1.40
1.1
1.1
69.4
93.5
%
—
9
64
7
29
2.42
1.39
1.3
1.2
—
—
—
0
0
6
23
2.61
1.36
1.2
1.7
—
—
—
0
0
24
151
1.59
1.34
1.1
1.1
—
—
—
0
0
11
54
2.04
1.32
3.3
2.3
7.9
7.8
mmol/l
—
5
29
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
71
554
1.29
1.27
1.1
1.1
1.0
5.9
u/ml
—
6
60
615
6604
0.91
1.26
4.0
4.4
24.0
21.7
%
2.69
289
3286
2062
21049
0.91
1.26
5.0
4.9
2.5
2.7
mmol/l
13.16
1857
19285
18
107
1.69
1.25
3.4
2.3
—
—
—
0
0
44
320
1.38
1.25
5.6
5.1
405.3
360.4
umol/l
1.14
36
285
10
49
2.04
1.22
1.1
1.2
—
—
—
0
0
151
1286
1.18
1.21
1.3
1.2
138.1
145.2
iu/ml
0.08
52
470
36
257
1.41
1.15
1.4
1.6
62.9
63.5
%
0.03
20
160
17
103
1.65
1.12
1.0
1.1
—
—
—
0
0
7
30
2.34
1.12
1.0
1.0
—
—
—
0
0
10
51
1.96
1.11
1.9
1.5
—
—
—
0
0
7
31
2.26
1.10
1.0
1.2
—
—
—
0
0
140
1197
1.18
1.09
3.6
3.3
4.2
4.5
pmol/l
2.68
125
1047
90
738
1.23
1.09
1.6
1.5
—
—
—
0
0
12
66
1.82
1.09
7.9
2.5
—
—
—
0
0
12
66
1.82
1.09
7.9
2.5
—
—
—
0
0
7
33
2.12
1.05
1.1
1.4
—
—
—
0
0
24
162
1.49
1.04
1.5
1.2
0.4
0.8
u/ml
0.42
11
76
240
2678
0.89
1.03
13.7
7.1
—
—
—
0
0
34
246
1.39
1.03
1.8
1.5
0.9
0.3
nmol/l
0.41
25
196
69
554
1.25
1.02
1.2
1.1
—
—
—
0
0
21
139
1.51
1.00
1.0
1.1
—
—
—
0
0
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
163
1856
0.87
0.97
1.8
2.0
—
—
—
0
0
6
28
2.15
0.91
1.0
1.0
—
—
—
0
0
23
159
1.45
0.91
1.5
1.4
12.9
21.9
u/ml
—
7
33
6
29
2.07
0.89
1.0
1.2
—
—
—
0
0
10
56
1.79
0.87
2.3
1.1
—
—
—
0
0
861
8233
1.07
0.86
4.6
5.1
3.7
3.7
ug/l
0.02
738
7346
8
44
1.82
0.85
1.0
1.1
—
—
—
0
0
2014
20481
0.93
0.85
4.5
4.4
1.4
1.4
mmol/l
13.06
1812
18756
36
274
1.32
0.84
1.1
1.1
10.0
2.6
u/ml
0.41
12
106
24
172
1.40
0.81
1.3
1.4
12.9
12.8
mmol/l
0.02
11
47
14
90
1.56
0.78
1.1
1.2
—
—
—
0
0
96
1109
0.86
0.74
2.0
1.9
—
—
—
0
0
243
2650
0.91
0.74
4.1
4.5
31.6
32.4
%
0.53
176
1775
18
125
1.44
0.72
1.1
1.1
1.2
1.2
u/l
—
9
63
51
416
1.23
0.72
1.7
1.8
—
—
—
0
0
30
229
1.31
0.71
1.2
1.3
—
—
—
0
0
7
41
1.71
0.70
1.1
1.1
—
—
—
0
0
76
887
0.85
0.68
1.9
1.8
—
—
—
0
0
38
302
1.26
0.68
1.1
1.1
—
—
—
0
0
39
312
1.25
0.66
1.8
1.7
—
—
—
0
0
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
5
29
1.73
0.64
1.2
1.6
—
—
—
0
0
5
29
1.73
0.64
2.4
2.1
—
—
—
0
0
12
79
1.52
0.62
1.5
2.8
1.0
1.7
ug/l
1.15
12
73
19
138
1.38
0.62
1.0
1.1
10.3
10.4
iu/ml
—
7
27
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
0.2
—
0
12
23
177
1.30
0.54
1.1
1.1
—
—
—
0
0
140
1273
1.11
0.53
1.4
1.3
16.9
56.3
au/ml
—
5
50
13
91
1.43
0.53
1.1
3.5
56.0
125.3
umol/l
—
8
56
9
64
1.41
0.51
1.0
1.1
—
—
—
0
0
50
425
1.18
0.51
1.3
1.5
—
—
—
0
0
42
499
0.84
0.50
2.1
1.9
3.4
4.7
iu/l
0.91
20
179
53
454
1.17
0.50
1.4
1.9
0.9
0.8
nmol/l
0.40
45
375
75
660
1.14
0.50
1.8
1.6
331.9
301.3
mu/l
0.37
69
604
2041
20640
0.95
0.49
4.6
4.4
4.3
4.6
mmol/l
17.72
1850
19037
5
31
1.61
0.43
2.6
1.4
120.2
123.1
ng/l
—
5
31
192
2053
0.93
0.42
1.9
2.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
1.7
—
0
9
531
5501
0.96
0.40
1.9
1.6
1.4
1.4
mmol/l
0.24
435
4603
183
1717
1.07
0.38
2.3
2.2
12.7
12.6
nmol/l
0.09
157
1508
9
67
1.34
0.38
1.0
1.1
—
—
—
0
0
9
68
1.32
0.37
1.0
1.1
—
—
—
0
0
33
282
1.17
0.35
1.7
1.3
0.7
0.6
nmol/l
0.13
33
267
28
239
1.17
0.31
1.4
1.4
280.6
282.3
pmol/l
0.01
22
182
7
54
1.30
0.30
1.0
3.2
—
—
—
0
0
11
84
1.31
0.30
5.0
1.8
—
—
—
0
0
262
2731
0.95
0.28
1.6
1.4
—
—
—
0
0
60
545
1.10
0.28
1.5
1.4
—
—
—
0
0
13
103
1.26
0.28
1.4
1.8
—
—
—
0
0
35
395
0.88
0.26
1.2
1.1
0.5
2.4
u/ml
2.40
15
184
21
179
1.17
0.25
4.0
4.9
45.2
42.7
u/ml
—
6
48
463
4752
0.97
0.24
2.9
3.1
0.8
0.8
ug/l
0.42
320
3224
21
243
0.86
0.23
1.6
1.3
7.9
7.4
mmol/l
0.23
16
173
1926
19395
0.97
0.23
6.5
5.9
39.6
40.1
mmol/mol
1.42
1753
17871
5
41
1.22
0.22
1.6
2.3
10.0
17.0
umol/l
—
5
41
13
107
1.22
0.21
1.1
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
11.5
—
0
8
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
74
697
1.06
0.18
1.9
1.8
—
—
—
0
0
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
33
357
0.92
0.14
1.4
1.6
—
—
—
0
0
107
1037
1.03
0.10
1.0
1.0
—
—
—
0
0
2045
20387
1.01
0.10
5.1
4.6
6.1
6.0
mmol/l
1.84
1860
18425
41
389
1.05
0.09
1.3
1.4
—
—
—
0
0
1973
19790
0.99
0.09
4.3
4.0
1.3
1.3
mmol/l
1.53
1787
17992
41
390
1.05
0.08
1.3
1.4
—
—
—
0
0
41
390
1.05
0.08
1.3
1.4
—
—
—
0
0
41
391
1.05
0.08
1.3
1.4
—
—
—
0
0
12
108
1.11
0.07
5.6
11.9
0.5
0.6
mmol/l
0.47
12
100
7
83
0.84
0.07
1.1
2.0
—
—
—
0
0
10
107
0.93
0.02
1.3
1.3
—
—
—
0
0
36
352
1.02
0.01
2.2
1.7
—
—
—
0
0
22
225
0.98
0.00
1.2
1.6
—
—
—
0
0
27
272
0.99
0.00
1.4
1.5
—
—
—
0
0
48
483
0.99
0.00
1.2
1.4
—
—
—
0
0
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
2.4
—
0
9
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_THROMBOCYTOPENIANAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_THROMBOCYTOPENIANAS | 2.959 [2.61, 3.36] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.239 |
During the follow-up period (1.1.1998 — 31.12.2019), 2428 out of 7148 females with D3_THROMBOCYTOPENIANAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_THROMBOCYTOPENIANAS | 3.095 [2.72, 3.52] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.474 |
During the follow-up period (1.1.1998 — 31.12.2019), 3444 out of 8372 males with D3_THROMBOCYTOPENIANAS died.
Mortality risk
Mortality risk for people of age
years, who have D3_THROMBOCYTOPENIANAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.242% | 0.6% |
| 5 | 1.655% | 4.353% |
| 10 | 4.4% | 10.977% |
| 15 | 8.294% | 19.863% |
| 20 | 14.628% | 32.578% |
Relationships between endpoints
↥Index endpoint: D3_THROMBOCYTOPENIANAS – Thrombocytopenia, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data